Skip to main content

Acyclovir News

Related terms: Acyclovir Topical

FDA Medwatch Alert: Eugia US LLC Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection 500 mg per 10 mL (50 mg/mL), Due to the Presence of Particulate Matter

September 26, 2022 – East Windsor, New Jersey, Eugia US LLC (formerly AuroMedics Pharma LLC) has initiated a voluntary recall of lot number AC22006 of AuroMedics Acyclovir Sodium Injection 500 mg per ...

FDA Medwatch Alert: Zydus Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection, 50 mg/mL Due to Crystallization

March 25, 2021 – Pennington, NJ, Zydus Pharmaceuticals (USA) Inc. is voluntarily recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, to the Hospital/User level after...

FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis

NEW YORK–(BUSINESS WIRE) April 01, 2019 –The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals' New Drug Application (NDA) for Avaclyr (acyclovir ophthalmic ointment) 3% for the ...

FDA Medwatch Alert: Acyclovir 400mg Tablets by Apace Packaging: Recall - Product Mix-up

ISSUE: Apace Packaging LLC is voluntarily recalling one lot of Acyclovir Tablet, USP, 400mg, 50ct Unit Dose, NDC# 50268-061-15, Lot Number 19900, to the retail level. These products have been...

BioAlliance Pharma's Sitavig Receives FDA Approval for the Treatment of Herpes Labialis

Paris, April 15, 2013 – BioAlliance Pharma SA (Euronext Paris - BIO), today announced the receipt of marketing authorization from the U.S. Food and Drug Administration (FDA) for Sitavig in the t...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cold sores, Herpes Simplex, Herpes Simplex - Suppression, Herpes Zoster

Acyclovir patient information at Drugs.com